LAUREN AGOSTINACCHIO: Open Payments
NPI 1831779933 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,426 in 56 payments from 15 companies in 2025. Trend: 2023 $701 · 2024 $1,039 · 2025 $2,426
Food & beverage: $2,357Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $499 |
| GENZYME CORPORATION | 9 | $416 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $340 |
| Botanix SB Inc | 4 | $225 |
| Organon LLC | 4 | $181 |
| Galderma Laboratories, L.P. | 6 | $170 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $145 |
| Regeneron Healthcare Solutions, Inc. | 1 | $136 |
| UCB, Inc. | 2 | $87 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $67 |
Products named: DUPIXENT, SKYRIZI, ILUMYA, SOFDRA, RINVOQ, NEMLUVIO, VTAMA, Cabtreo.
Industry payments across IL — which companies pay providers there.
